EUVIMEDEUVIMED entdecken
LeitlinieSystematische Übersicht

Screening for Speech and Language Delay and Disorders in Children

US Preventive Services Task Force, Michael J Barry, Wanda K Nicholson, Michael Silverstein, David Chelmow, Tumaini Rucker Coker, Esa M Davis, Katrina E Donahue, Carlos Roberto Jaén, Li Li, Carol M Mangione, Gbenga Ogedegbe und 6 weitere

JAMA · 23.01.2024 · 331 (4) · 329

DOI: 10.1001/jama.2023.26952 ↗

Kurz gefasst

Leitlinie in der Zeitschrift JAMA, erschienen am 23.01.2024. Verfasst von US Preventive Services Task Force und 17 weiteren Autor:innen. Beteiligte Einrichtung: Harvard Medical School, Boston, Massachusetts. Hauptthemen laut MEDLINE: Language Development Disorders, Mass Screening. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Speech and language delays and disorders can pose significant problems for children and their families. Evidence suggests that school-aged children with speech or language delays may be at increased risk of learning and literacy disabilities, including difficulties with reading and writing. Objective The US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate benefits and harms of screening for speech and language delay and disorders in children 5 years or younger. Population Asymptomatic children 5 years or younger whose parents or clinicians do not have specific concerns about their speech, language, hearing, or development. Evidence Assessment The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for speech and language delay and disorders in children who do not present with signs or symptoms or parent/caregiver concerns. Recommendation The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for speech and language delay and disorders in children 5 years or younger without signs or symptoms. (I statement)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Language Development DisordersMass ScreeningChildHumansAdvisory CommitteesChild, PreschoolAsymptomatic Diseases

Autor:innen und Institutionen

  • Harvard Medical School, Boston, Massachusetts.
  • George Washington University, Washington, DC.
  • Brown University, Providence, Rhode Island.
  • Virginia Commonwealth University, Richmond.
  • University of Washington, Seattle.
  • University of Maryland School of Medicine, Baltimore.

Zitieren

APA

US Preventive Services Task Force, Barry, M. J., Nicholson, W. K., Silverstein, M., Chelmow, D., Coker, T. R., Davis, E. M., Donahue, K. E., Jaén, C. R., Li, L., Mangione, C. M., Ogedegbe, G., Rao, G., Ruiz, J. M., Stevermer, J., Tsevat, J., Underwood, S. M., & Wong, J. B. (2024). Screening for Speech and Language Delay and Disorders in Children. JAMA, 331(4), 329. https://doi.org/10.1001/jama.2023.26952

Vancouver

US Preventive Services Task Force, Barry MJ, Nicholson WK, Silverstein M, Chelmow D, Coker TR, et al. Screening for Speech and Language Delay and Disorders in Children. JAMA. 2024;331(4):329. doi:10.1001/jama.2023.26952

BibTeX
@article{USPreventiveServicesTaskForce2024,
  author = {US Preventive Services Task Force, US Preventive Services Task Force and Barry, Michael J and Nicholson, Wanda K and Silverstein, Michael and Chelmow, David and Coker, Tumaini Rucker and Davis, Esa M and Donahue, Katrina E and Jaén, Carlos Roberto and Li, Li and Mangione, Carol M and Ogedegbe, Gbenga and Rao, Goutham and Ruiz, John M and Stevermer, James and Tsevat, Joel and Underwood, Sandra Millon and Wong, John B},
  title = {Screening for Speech and Language Delay and Disorders in Children},
  journal = {JAMA},
  year = {2024},
  volume = {331},
  number = {4},
  pages = {329},
  doi = {10.1001/jama.2023.26952}
}
Kostenlos starten →